An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital

Pneumocystis jirovecii pneumonia (PCP) is associated with high mortality in immunocompromised patients without human immunodeficiency virus infection. However, chemoprophylaxis is highly effective. In patients with solid tumours or haematologic malignancy, several risk factors for developing PCP hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Worth, L J, Dooley, M J, Seymour, J F, Mileshkin, L, Slavin, M A, Thursky, K A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361905/
https://www.ncbi.nlm.nih.gov/pubmed/15726101
http://dx.doi.org/10.1038/sj.bjc.6602412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361905/
https://www.ncbi.nlm.nih.gov/pubmed/15726101
http://dx.doi.org/10.1038/sj.bjc.6602412

Ejemplares similares